Feature | March 29, 2011

New Study Shows WBR Halves SPECT Dose, Acquisition Time

Wide beam reconstruction (WBR) reduces both dose and image acquisition time by 50 percent for myocardial perfusion SPECT (MPI), according to a new study published in the March-April 2011 issue of the Journal of Nuclear Cardiology. WBR is a software program by UltraSPECT for reconstructing nuclear medicine images. Researchers found that with either half the dose of Tc-99m sestamibi or half the acquisition time, WBR resulted in image quality superior to processing with today’s widely used OSEM (Ordered Subset Expectation Maximization) software. The study was conducted at St. Luke’s-Roosevelt Hospital and Columbia University College of Physicians and Surgeons in New York City.

“The escalating radiation levels of today’s advanced imaging exams is causing growing concern among the medical community and the public at large,” said Gordon DePuey, lead researcher and M.D., director of nuclear medicine at St. Luke’s-Roosevelt Hospital and Professor of Radiology at Columbia University. “There is significant pressure to minimize radiation dose, particular for MPI nuclear SPECT exams.”

In addition, the ongoing shortages of radiopharmaceuticals due to nuclear reactor downtime compound the need to minimize dosage. WBR’s reconstruction algorithm incorporating depth-dependent resolution recovery and image noise modeling to deliver a higher quality image with lower count density data. In the new MPI study, researchers evaluated images from 156 patients undergoing myocardial perfusion SPECT with a standard full-time acquisition protocol processed with routine OSEM methods.

The same patients underwent half-time acquisition, and the data were processed with the WBR algorithm. The images were acquired both at rest and following exercise or pharmacologic stress. A second study group of 160 patients received half of the standard radiopharmaceutical dose, with images acquired for the full standard acquisition time. These were processed using WBR only. All images were rated for quality by two observers unaware of the acquisition and processing methods. For both the lower dose and abbreviated acquisition time images, grading parameters included myocardial count density and uniformity, endocardial and epicardial edge definition, visualization and definition of the right ventricle and background noise. For the abbreviated acquisition time images only, SPECT perfusion defects also were examined. Overall, WBR half-time and half-dose image quality was judged as superior to OSEM image quality in both arms of the study. There was no statistically significant difference between the two SPECT protocols in identifying the extent or severity of perfusion defects.

“The results of this study demonstrate that WBR is a powerful means of reducing dose without sacrificing image quality and diagnostic accuracy,” DePuey said. “I would recommend that all nuclear medicine laboratories adopt some strategy for reducing patient radiation exposure incorporating WBR or others techniques that have proven effective.”

DePuey notes that new SPECT cameras with multiple focused detectors are another effective dose-reduction solution. “Wide beam reconstruction technology, however, is a software-only solution,” he says. “For sites unable to budget for a major hardware acquisition, WBR provides an equally effective, more affordable answer.”

For more information: www.ultraspect.com

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Overlay Init